Bristol-Myers Squibb (BMY) Tops Q4 EPS by 6c; Issues Light FY15 Outlook
Get Alerts BMY Hot Sheet
Price: $48.99 -0.31%
EPS Growth %: -318.0%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: -318.0%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $4.26 billion versus the consensus estimate of $4.02 billion.
Bristol-Myers Squibb sees FY2015 EPS of $1.55-$1.70, versus the consensus of $1.71.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) earnings and revenue exceed estimates in Q2, shares rise
- Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
- Visa (V) Tops Q2 EPS by 7c, offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!